Inhibition of Cisplatin-Induced Lipid Catabolism and Weight Loss by Ghrelin in Male Mice
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Cachexia, defined as an involuntary weight loss ≥5%, is a serious and dose-limiting side effect of chemotherapy that decreases survival in cancer patients. Alterations in lipid metabolism are thought to cause the lipodystrophy commonly associated with cachexia. Ghrelin has been proposed to ameliorate the alterations in lipid metabolism due to its orexigenic and anabolic properties. However, the mechanisms of action through which ghrelin could potentially ameliorate chemotherapy-associated cachexia have not been elucidated. The objectives of this study were to identify mechanisms by which the chemotherapeutic agent cisplatin alters lipid metabolism and to establish the role of ghrelin in reversing cachexia. Cisplatin-induced weight and fat loss were prevented by ghrelin. Cisplatin increased markers of lipolysis in white adipose tissue (WAT) and of β-oxidation in liver and WAT and suppressed lipogenesis in liver, WAT, and muscle. Ghrelin prevented the imbalance between lipolysis, β-oxidation, and lipogenesis in WAT and muscle. Pair-feeding experiments demonstrated that the effects of cisplatin and ghrelin on lipogenesis, but not on lipolysis and β-oxidation, were due to a reduction in food intake. Thus, ghrelin prevents cisplatin-induced weight and fat loss by restoring adipose tissue functionality. An increase in caloric intake further enhances the anabolic effects of ghrelin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghrelin induces adiposity in rodents
Tschöp, M., Smiley, D. L., & Heiman, M. L. (2000) · Nature · doi:10.1038/35038090 · Cited by 3,949
A role for ghrelin in the central regulation of feeding
Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K., & Matsukura, S. (2001) · Nature · doi:10.1038/35051587 · Cited by 3,443 · cited 5×
“3120 Garcia et al Ghrelin Inhibits Cisplatin-Induced Cachexia Endocrinology, September 2013, 154(9):3118–3129”
BackgroundInfluentialGhrelin action in the brain controls adipocyte metabolism
Theander-Carrillo, C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25811 · Cited by 465 · cited 2×
“Some (8, 32), but not all (35), previous studies report an increase in adiposity or lipogenesis following ghrelin administration.”
BackgroundSensory and sympathetic nervous system control of white adipose tissue lipolysis
Bartness, T. J., Shrestha, Y. B., Vaughan, C. H., Schwartz, G. J., & Song, C. K. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.031 · Cited by 289 · cited 1×
“drive to WAT (22, 25), these observations indicate that”
BackgroundFatty acid—induced inflammation and insulin resistance in skeletal muscle and liver
Boden, G. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0031-x · Cited by 276 · cited 1×
“Dysfunctional WAT is the source of excess FFAs and inflammatory mediators that cause and worsen insulin resistance (40).”
Background
Cited by
He, B., Nohara, K., Park, N., Park, Y.-S., Guillory, B., Zhao, Z., Garcia, J. M., Koike, N., Lee, C. C., Takahashi, J. S., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.007 · Cited by 507
Self-citationCancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways
Barreto, R., Mandili, G., Witzmann, F. A., Novelli, F., Zimmers, T. A., & Bonetto, A. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00472 · Cited by 183
Nishie, K., Yamamoto, S., Nagata, C., Koizumi, T., & Hanaoka, M. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.07.023 · Cited by 52
Wu, C.-T., Liao, J.-M., Ko, J.-L., Lee, Y.-L., Chang, H.-Y., Wu, C.-H., & Ou, C.-C. (2019) · Integrative Cancer Therapies · doi:10.1177/1534735419828832 · Cited by 32
The role of FGF21 in the metabolic adjustments required for exercise capacity
Abe, L., & Dantzer, R. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123940 · Cited by 5
Metadata
- Authors
- Garcia, J. M., Scherer, T., Chen, J.-A., Guillory, B., Nassif, A., Papusha, V., Smiechowska, J., Asnicar, M., Buettner, C., & Smith, R. G.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2013-07-05
- Volume
- 154
- Issue
- 9
- Pages
- 3118-3129
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W1990433760
- Cited by
- 118
- References
- 5
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of Cisplatin-Induced Lipid Catabolism and Weight Loss by Ghrelin in Male Mice. https://app.cochat.ai/papers/10.1210/en.2013-1179
- The paper
- Garcia, J. M., Scherer, T., Chen, J.-A., Guillory, B., Nassif, A., Papusha, V., Smiechowska, J., Asnicar, M., Buettner, C., & Smith, R. G. (2013). Inhibition of Cisplatin-Induced Lipid Catabolism and Weight Loss by Ghrelin in Male Mice. Endocrinology. https://doi.org/10.1210/en.2013-1179
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.